Capricor Therapeutics Inc (NASDAQ: CAPR) is 3.27% higher on its value in year-to-date trading and has touched a low of $2.68 and a high of $8.22 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CAPR stock was last observed hovering at around $5.55 in the last trading session, with the day’s loss setting it -0.5%.
Currently trading at $5.05, the stock is -22.38% and -6.95% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.94 million and changing -9.01% at the moment leaves the stock 7.73% off its SMA200. CAPR registered 19.67% gain for a year compared to 6-month gain of 77.82%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -25.63% loss in the last 1 month and extending the period to 3 months gives it a 22.28%, and is -18.94% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.83% over the week and 8.35% over the month.
Capricor Therapeutics Inc (CAPR) has around 102 employees, a market worth around $159.08M and $25.18M in sales. Fwd P/E is 51.79. Profit margin for the company is -88.52%. Distance from 52-week low is 88.43% and -38.57% from its 52-week high. The company has generated returns on investments over the last 12 months (-81.15%).
The EPS is expected to shrink by -16.26% this year
The shares outstanding are 31.15M, and float is at 28.79M with Short Float at 12.16%.
Capricor Therapeutics Inc (CAPR) Insider Activity
The most recent transaction is an insider purchase by Musket David B, the company’s Director. SEC filings show that Musket David B bought 410 shares of the company’s common stock on Oct 12 ’23 at a price of $2.75 per share for a total of $1128.0. Following the purchase, the insider now owns 31536.0 shares.
Capricor Therapeutics Inc disclosed in a document filed with the SEC on Oct 10 ’23 that COLLIER EARL M JR (Director) bought a total of 10,000 shares of the company’s common stock. The trade occurred on Oct 10 ’23 and was made at $2.83 per share for $28300.0. Following the transaction, the insider now directly holds 26856.0 shares of the CAPR stock.
Still, SEC filings show that on Oct 09 ’23, Musket David B (Director) acquired 5,083 shares at an average price of $2.82 for $14334.0. The insider now directly holds 31,126 shares of Capricor Therapeutics Inc (CAPR).
